NAFLD (NON-ALCOHOLIC FATTY LIVER DISEASE)
Clinical trials for NAFLD (NON-ALCOHOLIC FATTY LIVER DISEASE) explained in plain language.
Never miss a new study
Get alerted when new NAFLD (NON-ALCOHOLIC FATTY LIVER DISEASE) trials appear
Sign up with your email to follow new studies for NAFLD (NON-ALCOHOLIC FATTY LIVER DISEASE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to shrink fatty liver in 12 weeks
Disease control Recruiting nowThis study tests an experimental pill called HP515 for people with non-alcoholic fatty liver disease (NAFLD). About 80 adults with at least 10% liver fat will take the drug for 12 weeks. The main goal is to see if it reduces liver fat measured by MRI, while also checking safety a…
Matched conditions: NAFLD (NON-ALCOHOLIC FATTY LIVER DISEASE)
Phase: PHASE2 • Sponsor: Hinova Pharmaceuticals Inc. • Aim: Disease control
Last updated May 17, 2026 07:57 UTC
-
Simple ultrasound could replace painful liver biopsies for millions
Diagnosis Recruiting nowThis study is testing a new ultrasound method to measure fat in the liver without needles or expensive MRI scans. It involves 110 adults with or at risk for MASLD, a common liver condition linked to obesity and diabetes. If successful, this tool could make liver fat testing quick…
Matched conditions: NAFLD (NON-ALCOHOLIC FATTY LIVER DISEASE)
Phase: NA • Sponsor: ContextVision AB • Aim: Diagnosis
Last updated May 13, 2026 16:00 UTC